Skip to content

氙制药

US · XENE #2361 按市值排名 上市于 2015
33.49 -0.84 -2.45%
实时 - 追踪5344个代码 - 心跳于563秒前 · 2026-10-16 20:02

✦ 量化股权信号 计算方式说明

减持
  • 最近一期（2026/Q3）披露持股的机构数量减少了4家。
  • 机构持股总比例基本持平。

机构持股

机构持股比例
106.39% +0.02pp
机构数量
379 -4
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向分歧

机构在上一报告期增持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向出现分歧。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund72.12%
Hedge Fund27.18%
VC/PE Fund3.52%
Public Company1.40%
Insurance Company0.84%
Government Pension Fund0.73%
Private Company0.34%
Family Office/Trust0.26%
Individual/Insider0.16%

主要股东 截至 2026-07-31

FMR 10.18% · 9.86M 股
BlackRock 7.77% · 7.52M 股
Avoro Capital Advisors LLC 5.97% · 5.78M 股
T. Rowe Price Group, Inc. 5.59% · 5.42M 股
Polar Capital Holdings Plc 4.72% · 4.57M 股
Driehaus Capital Management LLC 4.56% · 4.42M 股
Janus Henderson Group plc 4.32% · 4.19M 股
Capital Research 3.33% · 3.22M 股
J.P. Morgan Asset Management, Inc. 2.61% · 2.53M 股
State Street Global Advisors 2.03% · 1.97M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 34次买入 · 16次卖出

姓名职务持股比例
Ian Mortimer Chief Executive Officer 0.07%
Dawn Svoronos Lead Independent Director 0.03%
Gary Patou Independent Director 0.03%
Thomas Kelly Chief Financial Officer 0.02%
Andrea DiFabio Chief Legal Officer 0.01%
C. Machado Independent Director 0.00%
Elizabeth Garofalo Independent Director 0.00%
Justin Gover Director 0.00%
Steven Gannon Independent Director 0.00%
Gillian Cannon Director 0.00%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-09-29 Thomas Kelly Chief Financial Officer Open Market Acquisition +15,000 $37.32
2026-09-29 Ian Mortimer Chief Executive Officer Open Market Acquisition +30,000 $37.38
2026-08-31 Dawn Svoronos Lead Independent Director Derivative Exercise and Retained +5,144 $8.15
2026-08-27 Christopher Kenney Chief Medical Officer Automatic Disposition -7,068 $60.17–60.98
2026-08-10 Steven Gannon Independent Director Open Market Disposition -10,000 $64.06
2026-06-04 Gary Patou Independent Director Automatic Disposition -1,322 $53.14
2026-06-04 Gillian Cannon Director Automatic Disposition -1,190 $53.14
2026-06-02 Justin Gover Director Other Derivative Acquisition +1,593 --
2026-06-02 Justin Gover Director Other Derivative Acquisition +10,507 $53.46
2026-06-02 Gary Patou Independent Director Other Derivative Acquisition +1,593 --
2026-06-02 Gary Patou Independent Director Other Derivative Acquisition +10,507 $53.46
2026-06-02 C. Machado Independent Director Other Derivative Acquisition +1,593 --
2026-06-02 C. Machado Independent Director Other Derivative Acquisition +10,507 $53.46
2026-06-02 Steven Gannon Independent Director Other Derivative Acquisition +1,593 --
2026-06-02 Steven Gannon Independent Director Other Derivative Acquisition +10,507 $53.46
2026-06-02 Dawn Svoronos Lead Independent Director Other Derivative Acquisition +1,593 --
2026-06-02 Dawn Svoronos Lead Independent Director Other Derivative Acquisition +10,507 $53.46
2026-06-02 Gillian Cannon Director Other Derivative Acquisition +1,593 --
2026-06-02 Gillian Cannon Director Other Derivative Acquisition +10,507 $53.46
2026-06-02 Elizabeth Garofalo Independent Director Other Derivative Acquisition +1,593 --

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:14 · 仅供参考，不构成投资建议，也未考虑您的具体情况。

氙制药 讨论区 0 条评论

发表评论